The Latest Breaking News from Pfizer

The highly transmissible 'Kraken' COVID variant is here. Experts say getting boosted is your best protection.

In the first real-world test of vaccine boosters specially designed to protect against the omicron variant, Israeli researchers have found that people 65 and over who got an updated jab were 81% less likely to be hospitalized with COVID-19 than those who did not.

The U.S. pharmaceutical giant is working on starting domestic production of the branded version of the Covid drug in the first half of this year

China will not include Pfizer’s COVID-19 treatment drug in a national reimbursement list that would have allowed patients to get it at a cheaper price throughout the country, saying it was too expensive

Social media users shared a range of false claims this week

Policymakers are now squarely focused on reviving the economy. But some analysts warned against ‘excessive optimism’ about when pre-pandemic growth rates will return

Biotech stocks can often be countercyclical, according to some market experts. We explore some biotech opportunities in this article.

A TORY MP has been accused of spreading “nonsense” about the Covid vaccine by a senior Conservative colleague.

Biopharmaceutical company Pfizer (PFE) is committed to executing its strategies to deliver breakthroughs to patients worldwide. The company saw a solid operational performance in the last reported quarter and raised its full-year 2022 outlook. Given PFE’s strong fundamentals and reliable dividends, this stock could be an ideal long-term investment. Read…

As case counts surge in China, rumors circulate about the effectiveness and safety of the made-in-China vaccines in use there. Here's what we know about CoronaVac and Sinopharm.

Health care centers from Guangzhou to Shijiazhuang and Beijing are slammed amid surging infections and severe shortages of medical workers